SGNE1/7B2 is epigenetically altered and transcriptionally downregulated in human medulloblastomas

Oncogene

Volumn 26, Issue 38, 2007, Pages 5662-5668

  Waha, A ^a,a,f,f   Koch, A ^a   Hartmann, W ^a   Milde, U ^a   Felsberg, J ^a   Hubner A ^a   Mikeska, T ^a   Goodyer, C G ^b   Sorensen N ^c   Lindberg, I ^d   Wiestler, O D ^e   Pietsch, T ^a  

^a UNIVERSITY OF BONN   (Germany)

^b RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^f UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

cRT PCR; DMH; Medulloblastoma; Methylation; SGNE1 7B2

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; BISULFITE; SECRETOGRANIN V;

5' UNTRANSLATED REGION; ARTICLE; CELL PROLIFERATION; CEREBELLUM; COLONY FORMATION; CONTROLLED STUDY; CPG ISLAND; DOWN REGULATION; EPIGENETICS; EXON; FETUS; GENE EXPRESSION; GENE INACTIVATION; GENE MUTATION; GENE SILENCING; GENETIC TRANSCRIPTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; HYBRIDIZATION; MEDULLOBLASTOMA; METHYLATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RESTRICTION MAPPING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; TRANSCRIPTION REGULATION; TUMOR BIOPSY; TUMOR CELL LINE;

AZACITIDINE; BASE SEQUENCE; CELL LINE, TUMOR; CELL PROLIFERATION; CEREBELLAR NEOPLASMS; CPG ISLANDS; DNA METHYLATION; DNA MODIFICATION METHYLASES; DOWN-REGULATION; ENZYME INHIBITORS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MEDULLOBLASTOMA; MOLECULAR SEQUENCE DATA; NEUROENDOCRINE SECRETORY PROTEIN 7B2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; TRANSCRIPTION, GENETIC;

EID: 34547801470     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210338     Document Type: Article

References (38)

1. Biegel JA, Rorke LB, Packer RJ, Sutton LN, Schut L, Bonner K et al. (1989). Isochromosome 17q in primitive neuroectodermal tumors of the central nervous system. Genes Chromosomes Cancer 1: 139-147.
2. Bigner SH, Friedman HS, Vogelstein B, Oakes WJ, Bigner DD. (1990). Amplification of the c-myc gene in human medulloblastoma cell lines and xenografts. Cancer Res 50: 2347-2350.
3. Bock C, Reither S, Mikeska T, Paulsen M, Walter J, Lengauer T. (2005). BiQ Analyzer: visualization and quality control for DNA methylation data from bisulfite sequencing. Bioinformatics 21: 4067-4068.
4. Braks JA, Broers CA, Danger JM, Martens GJ. (1996). Structural organization of the gene encoding the neuroendocrine chaperone 7B2. Eur J Biochem 236: 60-67.
5. Braks JA, Martens GJ. (1994). 7B2 is a neuroendocrine chaperone that transiently interacts with prohormone convertase PC2 in the secretorypathway. Cell 78: 263-273.
6. Cassidy SB. (1997). Prader-Willi syndrome. J Med Genet 34: 917-923.
7. Collini P, Sampietro G, Luksch R, Migliorini L, Boracchi P, Scopsi L. (1998). Differentiation in paediatric peripheral primitive neuroectodermal tumours of bone. A critical contribution to its assessment. Virchows Arch 432: 505-513.
8. Frühwald MC, O'Dorisio MS, Dai Z, Tanner SM, Balster DA, Gao X et al. (2001). Aberrant promoter methylation of previously unidentified target genes is a common abnormality in medulloblastomas - implications for tumor biology and potential clinical utility. Oncogene 20: 5033-5042.
9. Gardiner-Garden M, Frommer M. (1987). CpG islands in vertebrate genomes. J Mol Biol 196: 261-282.
10. Hartmann W, Digon-Söntgerath B, Koch A, Waha A, Endl E, Dani I et al. (2006). Phosphatidylinositol 3′-kinase/AKT signaling is activated in medulloblastoma cell proliferation and is associated with reduced expression of PTEN. Clin Cancer Res 12: 3019-3027.
11. Hsi KL, Seidah NG, de Serres G, Chretien M. (1982). Isolation and NH2-terminal sequence of a novel porcine anterior pituitarypoly peptide. Homologyto proinsulin, secretin and Rous sarcoma virus transforming protein TVFV60. FEBS Lett 147: 261-266.
12. Iguchi H, Chan JS, Seidah NG, Chretien M. (1984). Tissue distribution and molecular forms of a novel pituitary protein in the rat. Neuroendocrinology 39: 453-458.
13. Jeannotte R, Paquin J, Petit-Turcotte C, Day R. (1997). Convertase PC2 and the neuroendocrine polypeptide 7B2 are co-induced and processed during neuronal differentiation of P19 embryonal carcinoma cells. DNA Cell Biol 16: 1175-1187.
14. Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC et al. (2002). The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61: 215-225 discussion 226-9.
15. Kobayashi I, Jin L, Ruebel KH, Bayliss JM, Hidehiro O, Lloyd RV. (2003). Regulation of cell growth and expression of 7B2, PC2, and PC1/3 by TGFbeta 1 and sodium butyrate in a human pituitary cell line (HP75). Endocrine 22: 285-292.
16. Koch A, Tonn J, Kraus JA, Sörensen N, Albrecht NS, Wiestler OD et al. (1996). Molecular analysis of the lissencephaly gene 1 (LIS-1) in medulloblastomas. Neuropathol Appl Neurobiol 22: 233-242.
17. Kraus JA, Koch A, Albrecht S, von Deimling A, Wiestler OD, Pietsch T. (1996). Loss of heterozygosity at locus F13B on chromosome 1q in human medulloblastoma. Int J Cancer 67: 11-15.
18. Lindsey JC, Anderton JA, Lusher ME, Clifford SC. (2005). Epigenetic events in medulloblastoma development. Neurosurg Focus 19: E10.
19. Mattei MG, Mbikay M, Sylla BS, Lenoir G, Mattei JF, Seidah NG et al. (1990). Assignment of the gene for neuroendocrine protein 7B2 (SGNE1 locus) to mouse chromosome region 2[E3-F3] and to human chromosome region 15q11-q15. Genomics 6: 436-440.
20. Mbikay M, Seidah NG, Chretien M. (2001). Neuroendocrine secretory protein 7B2: structure, expression and functions. Biochem J 357: 329-342.
21. Mercapide J, Lopez de Cicco R, Bassi DE, Castresana JS, Thomas G, Klein-Szanto AJ. (2002). Inhibition of furinmediated processing results in suppression of astrocytoma cell growth and invasiveness. Clin Cancer Res 8: 1740-1746.
22. Pietsch T, Scharmann T, Fonatsch C, Schmidt D, Ockler R, Freihoff D et al. (1994). Characterization of five new cell lines derived from human primitive neuroectodermal tumors of the central nervous system. Cancer Res 54: 3278-3287.
23. Pomeroy SL, Tamayo P, Gaasenbee KM, Sturla LM, Angelo M, McLaughlin ME et al. (2002). Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 415: 436-442.
24. Reardon DA, Michalkiewicz E, Boyett JM, Sublett JE, Entrekin RE, Ragsdale ST et al. (1997). Extensive genomic abnormalities in childhood medulloblastoma by comparative genomic hybridization. Cancer Res 57: 4042-4047.
25. Roebroek AJ, Martens GJ, Duits AJ, Schalken JA, van Bokhoven A, Wagenaar SS et al. (1989). Differential expression of the gene encoding the novel pituitary polypeptide 7B2 in human lung cancer cells. Cancer Res 49: 4154-4158.
26. Russo C, Pellarin M, Tingby O, Bollen AW, Lamborn KR, Mohapatra G et al. (1999). Comparative genomic hybridization in patients with supratentorial and infratentorial primitive neuroectodermal tumors. Cancer 86: 331-339.
27. Schmidt G, Sirois F, Anini Y, Kauri LM, Gyamera-Acheampong C, Fleck E et al. (2006). Differences of pancreatic expression of 7B2 between C57BL/6J and C3H/ HeJ mice and genetic polymorphisms at its locus (Sgne1). Diabetes 55: 452-459.
28. Seidah NG, Hsi KL, de Serres G, Rochemont J, Hamelin J, Antakly T et al. (1983). Isolation and NH2-terminal sequence of a highly conserved human and porcine pituitary protein belonging to a new superfamily. Immunocytochemical localization in pars distalis and pars nervosa of the pituitary and in the supraoptic nucleus of the hypothalamus. Arch Biochem Biophys 225: 525-534.
29. Seidel B, Dong W, Savaria D, Zheng M, Pintar JE, Day R. (1998). Neuroendocrine protein 7B2 is essential for proteolytic conversion and activation of proprotein convertase 2 in vivo. DNA Cell Biol 17: 1017-1029.
30. Strausberg RL, Feingold EA, Grouse LH, Derge JG, Klausner RD, Collins FS et al. (2002). Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proc Natl Acad Sci USA 99: 16899-16903.
31. Uziel T, Zindy F, Sherr CJ, Roussel MF. (2006). The CDK inhibitor p18Ink4c is a tumor suppressor in medulloblastoma. Cell Cycle 5: 363-365.
32. Waha A, Güntner S, Huang TH, Yan PS, Arslan B, Pietsch T et al. (2005). Epigenetic silencing of the protocadherin family member PCDH-gamma-A11 in astrocytomas. Neoplasia 7: 193-199.
33. Waha A, Koch A, Meyer-Puttlitz B, Weggen S, Sörensen N, Tonn JC et al. (2003). Epigenetic silencing of the HIC-1 gene in human medulloblastomas. J Neuropathol Exp Neurol 62: 1192-1201.
34. Waha A, Watzka M, Koch A, Pietsch T, Przkora R, Peters N et al. (1998). A rapid and sensitive protocol for competitive reverse transcriptase (cRT) PCR analysis of cellular genes. Brain Pathol 8: 13-18.
35. Waldbieser GC, Aimi J, Dixon JE. (1991). Cloning and characterization of the rat complementary deoxyribonucleic acid and gene encoding the neuroendocrine peptide 7B2. Endocrinology 128: 3228-3236.
36. Westphal CH, Muller L, Zhou A, Zhu X, Bonner-Weir S, Schambelan M et al. (1999). The neuroendocrine protein 7B2 is required for peptide hormone processing in vivo and provides a novel mechanism for pituitary Cushing's disease. Cell 96: 689-700.
37. Yan PS, Chen CM, Shi H, Rahmatpanah F, Wei SH, Caldwell CW et al. (2001). Dissecting complex epigenetic alterations in breast cancer using CpG island microarrays. Cancer Res 61: 8375-8380.
38. Zhu X, Lindberg I. (1995). 7B2 facilitates the maturation of proPC2 in neuroendocrine cells and is required for the expression of enzymatic activity. J Cell Biol 129: 1641-1650.